Zhi Wang1, Liaoliao Li2, Huijuan Zhao2, Shuling Peng3, Zhiyi Zuo4. 1. Department of Anesthesiology, University of Virginia, Charlottesville, VA, USA; Department of Anesthesiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. 2. Department of Anesthesiology, University of Virginia, Charlottesville, VA, USA. 3. Department of Anesthesiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. 4. Department of Anesthesiology, University of Virginia, Charlottesville, VA, USA. Electronic address: zz3c@virginia.edu.
Abstract
BACKGROUND: Obesity can cause pathological changes in organs. We determined the effects of chronic high fat diet (HFD) and intermittent fasting, a paradigm providing organ protection, on mouse heart. METHODS: Seven-week old CD1 male mice were randomly assigned to control, HFD and intermittent fasting groups. Control mice had free access to regular diet (RD). RD was provided every other day to mice in the intermittent fasting group. Mice in HFD group had free access to HFD. Their left ventricles were harvested 11 months after they had been on these diet regimens. RESULTS: HFD increased cardiomyocyte cross-section area and fibrosis. HFD decreased active caspase 3, an apoptosis marker, and the ratio of microtubule-associated protein 1A/1B-light chain 3 (LC3) II/LC3I, an autophagy marker. HFD increased the phospho-glycogen synthase kinase-3β (GSK-3β) at Ser9, a sign of GSK-3β inhibition. Nuclear GATA binding protein 4 and yes-associated protein, two GSK-3β targeting transcription factors that can induce hypertrophy-related gene expression, were increased in HFD-fed mice. Mice on intermittent fasting did not have these changes except for the increased active caspase 3 and decreased ratio of LC3II/LC3I. CONCLUSIONS: These results suggest that chronic HFD induces myocardial hypertrophy and fibrosis, which may be mediated by GSK-3β inhibition.
BACKGROUND:Obesity can cause pathological changes in organs. We determined the effects of chronic high fat diet (HFD) and intermittent fasting, a paradigm providing organ protection, on mouse heart. METHODS: Seven-week old CD1 male mice were randomly assigned to control, HFD and intermittent fasting groups. Control mice had free access to regular diet (RD). RD was provided every other day to mice in the intermittent fasting group. Mice in HFD group had free access to HFD. Their left ventricles were harvested 11 months after they had been on these diet regimens. RESULTS: HFD increased cardiomyocyte cross-section area and fibrosis. HFD decreased active caspase 3, an apoptosis marker, and the ratio of microtubule-associated protein 1A/1B-light chain 3 (LC3) II/LC3I, an autophagy marker. HFD increased the phospho-glycogen synthase kinase-3β (GSK-3β) at Ser9, a sign of GSK-3β inhibition. Nuclear GATA binding protein 4 and yes-associated protein, two GSK-3β targeting transcription factors that can induce hypertrophy-related gene expression, were increased in HFD-fed mice. Mice on intermittent fasting did not have these changes except for the increased active caspase 3 and decreased ratio of LC3II/LC3I. CONCLUSIONS: These results suggest that chronic HFD induces myocardial hypertrophy and fibrosis, which may be mediated by GSK-3β inhibition.
Authors: Christa M Studzinski; Feng Li; Annadora J Bruce-Keller; Sun Ok Fernandez-Kim; Le Zhang; Adam M Weidner; William R Markesbery; M Paul Murphy; Jeffrey N Keller Journal: J Neurochem Date: 2008-11-27 Impact factor: 5.372
Authors: Yinan Hua; Yingmei Zhang; Asli F Ceylan-Isik; Loren E Wold; Jennifer M Nunn; Jun Ren Journal: Basic Res Cardiol Date: 2011-09-09 Impact factor: 17.165
Authors: Bettina von Sarnowski; Jukka Putaala; Ulrike Grittner; Beate Gaertner; Ulf Schminke; Sami Curtze; Roman Huber; Christian Tanislav; Christoph Lichy; Vida Demarin; Vanja Basic-Kes; E Bernd Ringelstein; Tobias Neumann-Haefelin; Christian Enzinger; Franz Fazekas; Peter M Rothwell; Martin Dichgans; Gerhard J Jungehulsing; Peter U Heuschmann; Manfred Kaps; Bo Norrving; Arndt Rolfs; Christof Kessler; Turgut Tatlisumak Journal: Stroke Date: 2012-11-13 Impact factor: 7.914
Authors: Niranjana Natarajan; Ana Vujic; Jishnu Das; Annie C Wang; Krystal K Phu; Spencer H Kiehm; Elisabeth M Ricci-Blair; Anthony Y Zhu; Kelli L Vaughan; Ricki J Colman; Julie A Mattison; Richard T Lee Journal: JCI Insight Date: 2019-09-19
Authors: Isha Agarwal; Nicole L Glazer; Eddy Barasch; Luc Djousse; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Siscovick; George L King; Ken J Mukamal Journal: Metabolism Date: 2015-07-21 Impact factor: 8.694